AlloVir, Inc. (ALVR)
NASDAQ: ALVR · IEX Real-Time Price · USD
0.775
+0.024 (3.19%)
At close: May 17, 2024, 4:00 PM
0.760
-0.015 (-1.99%)
After-hours: May 17, 2024, 6:57 PM EDT
AlloVir Stock Forecast
ALVR's stock price has decreased by -81.32% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AlloVir stock have an average target of 5.88, with a low estimate of 1.00 and a high estimate of 20. The average target predicts an increase of 658.32% from the current stock price of 0.78.
Analyst Consensus: Hold
* Price targets were last updated on Dec 26, 2023.
Analyst Ratings
The average analyst rating for AlloVir stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $17 → $1 | Strong Buy → Sell | Downgrades | $17 → $1 | +28.97% | Dec 26, 2023 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $1 | Buy → Hold | Downgrades | $1 | +28.97% | Dec 22, 2023 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $27 → $1.5 | Buy → Hold | Downgrades | $27 → $1.5 | +93.45% | Dec 22, 2023 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Dec 22, 2023 |
| B of A Securities | B of A Securities | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +2,092.42% | Aug 18, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.45
from -1.83
EPS Next Year
-0.30
from -0.45
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.25 | - | -0.45 |
| Avg | -0.45 | -0.30 | -0.44 |
| Low | -0.57 | -0.49 | -0.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.